Company Filing History:
Years Active: 2018-2021
Title: Marcel Breuning: Innovator in Pharmaceutical Chemistry
Introduction
Marcel Breuning is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of three patents. His work focuses on improving the solubility and stability of compounds used in cell culture media and pharmaceutical compositions.
Latest Patents
Breuning's latest patents include a crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol. This invention can be prepared as a pharmaceutical composition, showcasing his innovative approach to drug formulation. Another significant patent relates to cell culture media that comprise inorganic ester derivatives of tyrosine and/or cysteine. This invention addresses the poor solubility of tyrosine and the insufficient stability of cysteine in cell culture media by substituting them with inorganic ester derivatives, such as phosphorylated derivatives.
Career Highlights
Marcel Breuning is currently associated with Merck Patent GmbH, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the effectiveness of pharmaceutical compounds, making a lasting impact in the industry.
Collaborations
Breuning collaborates with esteemed colleagues, including Joerg Von Hagen and Christian Jasper. Their combined expertise fosters a productive environment for innovation and development in pharmaceutical sciences.
Conclusion
Marcel Breuning's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of effective pharmaceutical compositions and cell culture media.